Bayer | BAYN - Sales Revenues

Stock Price
41.85
Daily Change
-0.74 -1.74%
Monthly
-10.46%
Yearly
83.97%
Q1 Forecast
42.20

Bayer reported EUR9.66B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Air Liquide EUR 13.22B 6.62B Dec/2025
Akzo Nobel EUR 2.37B 180M Dec/2025
Alcon AG USD 2.7B 110M Dec/2025
Amarin USD 49.67M 23.07M Sep/2025
Arkema EUR 2.11B 80M Dec/2025
AstraZeneca USD 15.5B 313M Dec/2025
BASF EUR 14.33B 1.44B Sep/2025
Bayer EUR 9.66B 1.08B Sep/2025
Beiersdorf EUR 2.35B 150M Sep/2025
Corteva USD 3.91B 1.29B Dec/2025
Covestro EUR 3.17B 210M Sep/2025
Essilor EUR 14.47B 7.6B Dec/2025
Fresenius EUR 5.88B 400M Dec/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
Genmab DKK 5.86B 580M Jun/2025
Givaudan CHF 1.87B 1.51B Jun/2024
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GRIFOLS EUR 1.87B 20M Sep/2025
Henkel EUR 5.16B 5.61B Jun/2025
Hikma Pharmaceutical USD 829M 758M Jun/2025
Johnson Matthey GBP 1.28B 4.76B Sep/2025
Linde USD 8.62B 120M Sep/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.32B 890M Sep/2025
Novartis USD 13.91B 144M Sep/2025
Nutrien USD 7.03B 1.07B Dec/2025
Philips EUR 5.1B 797M Dec/2025
PPG Industries USD 3.91B 170M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
SAP EUR 9.68B 600M Dec/2025
Solvay EUR 995M 45M Dec/2025
UCB EUR 3.49B 129M Jun/2025
Umicore EUR 10.68B 8.89B Dec/2025
Vinci EUR 19.72B 320M Dec/2025